Pricing
  1. JP-listed companies
  2. AFC-HD AMS Life Science Co.,Ltd.
  3. Financials
  4. Effective tax rate (%)

AFC-HD AMS Life Science Co.,Ltd.【JP:2927】

Market cap
¥12.7B
P/E ratio
8.5x
AFC-HD Amus Life Science develops and sells health foods, cosmetics, and pharmaceuticals to consumers and medical institutions across multiple channels.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndEffective tax rate (%) (Million JPY)YoY (%)
Aug 31, 202530-13.49%
Aug 31, 202434.6+30.38%
Aug 31, 202326.6-28.35%
Aug 31, 202237.1+21.00%
Aug 31, 202130.6+2.84%
Aug 31, 202029.8-1.75%
Aug 31, 201930.3+19.60%
Aug 31, 201825.4+53.89%
Aug 31, 201716.5-50.28%
Aug 31, 201633.1-16.91%
Aug 31, 201539.9-4.16%
Aug 31, 201441.6

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)